
Previously, Susvimo was called the Port Delivery System with ranibizumab in the United States
Previously, Susvimo was called the Port Delivery System with ranibizumab in the United States
The hearing aid glasses from EssilorLuxottica received CE marking under the Medical Devices Regulation of the EMA
OCU400 is the first gene therapy from the biotechnology company to move forward into Phase 3 with a broad retinitis pigmentosa (RP) indication
Pavblu and Skojoy, both from Amgen, are indicated for the treatment of neovascular age-related macular degeneration
The lead gene therapy candidate, AXV-101, is expected to enter clinical development in mid-2025
The gel addresses necrotic retinal cell death in dry age-related macular degeneration and geographic atrophy without requiring injections
Investigators examined the connection between amblyopia, components of the metabolic syndrome and individual cardiometabolic diseases
The extension includes lenses that range from minus power of -13.00 diopters to cylindrical power up to 4.00 diopters
The approval of Syfovre makes it the first and only approved treatment for GA in Australia.
The centre will facilitate research and access to resources for the 450,000 residents of the UK who are affected by sight and hearing loss
The scientific outputs from MACUSTAR’s study could impact more than 200 million patients with AMD globally
Diana V. Do, MD, spoke on behalf of the HELIOS investigators at the Hawaiian Eye and Retina 2025 Meeting, in Kauai, HI
Ultrasounds reveal the distinct feature within the vitreous anterior, a promising diagnostic indicator for ocular pathologies
ARCATUS or ARVN001 was developed by Clearside Biomedical and commercialised in the Asia-Pacific region by Arctic Vision
Predictive software will use retinal imaging to identify patient risk for Alzheimer and other neurodegenerative diseases
The study findings suggest that patients should be educated about adherence to cold storage guidelines
Participants wore high-add multifocal soft contact lenses for 2 years and single-vision lenses during the third year to determine if rebound occurred
The updated device is designed to meet market diagnostic needs, including within geographic atrophy research
Autonomous, AI-based screening consistently resulted in more patients screened with greater cost savings, investigators said
A case report highlights the pathogen’s potential to cause severe, devastating ocular infections, despite aggressive treatment
The transferrin vectorised therapy is being investigated for use in patients with dry age-related macular degeneration and geographic atrophy
The company, which has European headquarters in Basel, Switzerland, plans to use the funds for a non-interventional, observational study and a first-in-human clinical trial
Advances in biometric technology and IOL calculation formulas have enabled refractive accuracy of cataract and clear lens exchange (CLE) surgery, but IOL power selection remains challenging in some cases. I have found that the ZEISS IOL Power Calculation Service (IPCS) is a valuable asset to help me in these uncertain situations.
The laser integrates into the Corneal Refractive Workflow alongside the Visumax 800 and SMILE pro software
The commercialisation agreements for the biosimilar to aflibercept (Eylea) cover Israel, major parts of Europe and the Asia-Pacific Region
The launch follows a CE Mark received in late 2024
The study built on previous research indicating specific retinal variables can serve as disease-related biomarkers in neurodegenerative diseases
The authors investigated systemic adverse events associated with commercial mydriatics administered during retinopathy of prematurity (ROP) screening
ViGeneron, based in Munich, also received approval for dose escalation in the ongoing phase 1b clinical trial